CSF3R and neoplasm: Alternative mechanisms, independent of G-CSFR-driven autocrine tumor cell proliferation, appear to promote G-CSF-mediated tumor progression in other types of malignancies such as experimental metastatic bone tumors [88] and Ewing sarcoma (ES) [89].